EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Drug‐Induced QT Prolongation: Associations Between Risk Classifications in a Swedish Clinical Decision Support System and Clinical Outcomes

Ola Nordqvist iD, Olof Björneld iD, Patrick Bergman iD, Björn Wettermark iD, Alisa Lincke iD, Marine L Andersson iD, Tora Hammar iD

Clinical Pharmacology & Therapeutics · 2026

DOI: 10.1002/cpt.70121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2026. Verfasst von Ola Nordqvist und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Optometry, eHealth Institute, Faculty of Health and Life Sciences, Linnaeus University, Kalmar, Sweden. Hauptthemen laut MEDLINE: Decision Support Systems, Clinical, Long QT Syndrome, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Potential adverse drug events can be signaled in Clinical Decision Support Systems (CDSSs). This study validated a Swedish CDSS (Janusmed Risk Profile) by investigating associations between calculated risk classifications of drugs with QT‐prolonging potential and registered related clinical outcomes. Subjects living in Kalmar County, Sweden, between 2011 and 2020 exposed to risk drugs (risk level I: somewhat increased risk, II: moderate increased risk, III: significant increased risk) were extracted from regional electronic health records and matched to controls (risk level 0: no known increased risk) by age, sex, and index date. Ventricular arrhythmia (VA), Torsade de Pointes, cardiac arrest and death were outcomes followed for one year. Logistic regression analysis was performed adjusted for age, sex, number of drugs, days in hospital and previous diagnosis. Among the 188,453 subjects, a higher proportion of those classified by the CDSS as having a risk of QT prolongation experienced VA compared to controls (risk level I = 0.26%, II = 0.34%, III = 0.71% vs risk level 0 = 0.17%). When adjusting for other risk factors, the association decreased, but risk level III remained significant with OR 2.1 (95% CI 1.6–2.9) compared to controls. Similar results were seen for the other outcomes. Although there was an association between CDSS risk classifications and clinical outcomes, only a few subjects are affected, and other factors, such as previous diagnosis, play an important role. The need for multifactorial CDSS algorithms is thus crucial to better guide prescribers in finding high‐risk patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Decision Support Systems, ClinicalLong QT SyndromeDrug-Related Side Effects and Adverse ReactionsHumansSwedenMaleFemaleMiddle AgedAgedRisk AssessmentRisk FactorsAdultTorsades de PointesElectronic Health Records

Autor:innen und Institutionen

  • Department of Medicine and Optometry, eHealth Institute, Faculty of Health and Life Sciences, Linnaeus University, Kalmar, Sweden.
  • The Pharmaceutical Department, Region Kalmar County, Kalmar, Sweden.
  • Department of Computer Science and Media Technology, Data Intensive Sciences and Applications (DISA), Faculty of Technology, Linnaeus University, Kalmar, Sweden.
  • Business Intelligence, IT Division, Region Kalmar County, Kalmar, Sweden.
  • Department of Pharmacy, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

ORCID-Profile: Ola Nordqvist, Olof Björneld, Patrick Bergman, Björn Wettermark, Alisa Lincke, Marine L Andersson, Tora Hammar

Zitieren

APA

Nordqvist, O., Björneld, O., Bergman, P., Wettermark, B., Lincke, A., Andersson, M. L., & Hammar, T. (2026). Drug‐Induced QT Prolongation: Associations Between Risk Classifications in a Swedish Clinical Decision Support System and Clinical Outcomes. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70121

Vancouver

Nordqvist O, Björneld O, Bergman P, Wettermark B, Lincke A, Andersson ML, et al. Drug‐Induced QT Prolongation: Associations Between Risk Classifications in a Swedish Clinical Decision Support System and Clinical Outcomes. Clinical Pharmacology & Therapeutics. 2026. doi:10.1002/cpt.70121

BibTeX
@article{Nordqvist2026,
  author = {Nordqvist, Ola and Björneld, Olof and Bergman, Patrick and Wettermark, Björn and Lincke, Alisa and Andersson, Marine L and Hammar, Tora},
  title = {Drug‐Induced QT Prolongation: Associations Between Risk Classifications in a Swedish Clinical Decision Support System and Clinical Outcomes},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1002/cpt.70121}
}
Kostenlos starten →